We found that the expression of PSMD9 was significantly correlated with the malignancy grade and metastasis in HCC patients in the TCGA and ICGC-LIRI-JP cohorts (Fig. 1E-F). The gene discussed is PSMD9; the disease is hepatocellular carcinoma.